My first thought when reading this case was doesn’t anyone else have a garage door that will not close even when there is nothing in the way? Or that goes on psychotic ‘opening and closing’ benders for no apparent reason? I can’t be the only one – clearly improved garage door openers are needed in […]
Pharma Tech Solutions, Inc., Decision IT Corp., v. LifeScan, Inc., LifeScan Scotland, LTD., Johnson and Johnson, Appeal 2019-1163, decided November 22, 2019. pharma-tech-solutions-v-lifescan Procedural Background Pharma Tech Solutions, Inc. sued LifeScan, Inc. for infringement of US Patent Nos. 6,153,069 and 6,413,411, both directed to blood glucose monitoring systems. As originally presented, the claims of the […]
As due diligence for an appeal in a difficult case I have been prosecuting for a client, I looked through the decisions issued by PTAB out of Tech Center 1700 in October of 2019. Here are some things I found interesting: The Board heard 80 appeals, and reversed the Examiner 24 times. In the reversals: […]
In 2018, the Federal Circuit reversed the District Court of Delaware’s refusal to grant Liqwd a preliminary injunction against L’Oreal Liqwd v L’Oreal Preliminary Injunction. Many reported earlier this summer on L’Oreal’s expensive loss to Olaplex in the District Court of Delaware. (See, e.g., https://www.bloomberg.com/news/articles/2019-08-12/l-oreal-owes-startup-91-million-for-stealing-its-trade-secrets). L’Oreal has now been dealt another blow by the Federal […]
David Fought and Martin Clanton (“Appellants”, In re Fought and Clanton) are the named inventors on US Patent Application No. 13/507528 directed to a “travel trailer.” The Examiner rejected the claim 1 under 35 USC 102(b) over a reference describing a conventional truck trailer and claim 2 under 35 USC 102(b) over a reference describing […]
HZNP Medicines LLC, Horizon Pharma USA Inc., v. Actavis Laboratories UT, Inc., HZNP v Horizon Pharma Appeal No. 2017-2149 et al, decided October 10, 2019 was an appeal from the District Court of New Jersey’s judgment of invalidity and noninfringement. Amongst others, at issue was the District Court’s construction of the transitional phrase “consisting essentially […]
On October 15, 2019, the PTAB designated as informative two decisions illustrating the bounds of use of “design choice” by Examiners in support of an obviousness rejection. In Ex parte Spangler, Appeal No. 2018-003800 (Feb. 20, 2019) Ex-parte-Spangler, Appellants’ claimed invention related to a featherseal incorporating two longitudinal tabs that engage with a post on […]
In American Axle Manufacturing Inc. v. Neapco Holdings LLC, case number 18-1763, AAM v Neapco the US Court of Appeals for the Federal Circuit affirmed a grant of summary judgement from the District of Delaware finding American Axle Manufacturing’s (AAM’s) method ineligible for patent protection under 35 USC §101. AAM sued Neapco for patent infringement […]
Honeywell International Inc. (“Honeywell”) owns US Patent No. 9,157,017 (the ‘017 patent) directed to fluoroalkene compounds used in refrigeration systems. The ‘017 patent recites a chain of priority dating back to 2002. During prosecution of the ‘017 patent, Honeywell filed a preliminary amendment in which all 20 original claims were replaced with 20 claims directed […]
The release Update with Appendix Oct 2019 includes guidance on determining whether a claim recites one or more abstract idea(s) and if so, if the abstract idea(s) is/are limited to practical applications of the idea, additional examples in the life sciences and data processing categories and a table of cases from the Supreme Court and […]